You have 9 free searches left this month | to do more

enzalutamide

Enzalutamide is a drug used to treat Prostate Cancer, Castration-Resistant Prostate Carcinoma, Prostatic Neoplasms, and other conditions. Enzalutamide is being actively studied in 106 studies and prior, has been studied in 65.

Top SponsorsTop SitesTop Investigators
PfizerMemorial Sloan Kettering Cancer CenterTom Beer
Astellas Pharma Global Development, Inc.Duke University Medical CenterMamta Parikh
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsDana Farber Cancer InstituteMary-Ellen Taplin, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
Recruiting
  • Prostate Cancer
  • Enzalutamide
  • EPI-7386 with Enzalutamide
  • Port Saint Lucie, Florida
  • +3 more
2022-03-29
Mar 29, 2022
N
Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-02-05
Feb 5, 2022
M
Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-10-25
Oct 25, 2021
Z
Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Lakewood, Colorado
  • +4 more
2022-02-23
Feb 23, 2022
S
Recruiting
  • Castration Resistant Metastatic Prostate Cancer
  • Testosterone cypionate
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
2022-02-01
Feb 1, 2022
U
Active, not recruiting
  • Prostate Cancer
  • Enzalutamide
  • Metformin Hydrochloride
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2022-01-11
Jan 11, 2022
D
Completed
  • Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-01-05
Jan 5, 2022
M
Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2022-02-23
Feb 23, 2022
N
Not yet recruiting
  • Prostate Cancer
  • +7 more
  • (no location specified)
2022-01-12
Jan 12, 2022
S
Active, not recruiting
  • Cancer of the Prostate
  • Prostate Cancer
  • Aarau, Switzerland
  • +15 more
2021-09-27
Sep 27, 2021
M
Recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2022-02-23
Feb 23, 2022
U
Terminated
  • Prostatic Neoplasms
  • Pelvic Nodal
  • Enzalutamide
  • +2 more
  • San Francisco, California
    University of California San Francisco
2021-09-14
Sep 14, 2021
R
Terminated
  • Clear Cell Renal Cell Carcinoma
  • Stage I Renal Cell Cancer
  • Enzalutamide
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
2021-09-14
Sep 14, 2021
R
Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Enzalutamide
  • Nijmegen, Netherlands
  • +2 more
2021-07-11
Jul 11, 2021
M
Terminated
  • Metastatic Castration-resistant Prostate Cancer
  • Myrtle Beach, South Carolina
    Research Site
2022-03-30
Mar 30, 2022
U
Suspended
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +1 more
2021-12-17
Dec 17, 2021
T
Completed
  • Castration-resistant Prostate Cancer
  • Osaka, Japan
    Osaka City University Graduate School of Medicine
2021-09-08
Sep 8, 2021
D
Active, not recruiting
  • Intermediate Risk Prostate Cancer
  • Enzalutamide
  • External Beam Radiation
  • Boston, Massachusetts
  • +2 more
2021-07-26
Jul 26, 2021
S
Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Testosterone Undecanoate
  • Enzalutamide
  • Baltimore, Maryland
    Johns Hopkins Hospital
2022-03-02
Mar 2, 2022
H
Completed
  • Pancreatic Cancer
  • Enzalutamide
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-08-16
Aug 16, 2021
A
Recruiting
  • Prostate Cancer
  • Bone Metastases
  • Zoledronic Acid
  • Enzalutamide
  • Brescia, Italy
    Azienda Ospedaliera Spedali Civili di Brescia
2022-03-04
Mar 4, 2022
I
Recruiting
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • São Paulo, SP, Brazil
    Instituto do Câncer do Estado de São Paulo
2021-05-14
May 14, 2021
C
Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
2021-08-03
Aug 3, 2021